# EWSB Bancorp, Inc.: financial statements, quarterly

EWSB · OTC · CIK 2013792 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ewsb.md) · [Financials](/companies/ewsb/financials.md) · [Filings](/companies/ewsb/filings.md) · [Insiders](/companies/ewsb/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ewsb/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2023-09-30) | period not labelled (2023-12-31) | period not labelled (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Income tax | $k | [(33.0)](/filings/0001558370-24-015538.md) | [(206) d](/filings/0001558370-25-003534.md) | [(162)](/filings/0001558370-25-007741.md) | [(199)](/filings/0001558370-25-011551.md) | [(150)](/filings/0001104659-25-112443.md) | [(224) d](/filings/0001104659-26-034594.md) | [(228)](/filings/0001104659-26-058614.md) | [(146)](/filings/0001104659-26-094846.md) | [3,177](/filings/0001104659-25-112443.md) | [49.2 d](/filings/0001104659-26-034594.md) | [0.0](/filings/0001104659-26-058614.md) | [0.0](/filings/0001104659-26-094846.md) |
| Net income | $k | [(122)](/filings/0001558370-24-015538.md) | [(404) d](/filings/0001558370-25-003534.md) | [(377)](/filings/0001558370-25-007741.md) | [(463)](/filings/0001558370-25-011551.md) | [(332)](/filings/0001104659-25-112443.md) | [(528) d](/filings/0001104659-26-034594.md) | [(569)](/filings/0001104659-26-058614.md) | [(279)](/filings/0001104659-26-094846.md) | [(3,341)](/filings/0001104659-25-112443.md) | [11.0 d](/filings/0001104659-26-034594.md) | [(365)](/filings/0001104659-26-058614.md) | [(315)](/filings/0001104659-26-094846.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | [(0.81)](/filings/0001104659-26-058614.md) | [(0.40)](/filings/0001104659-26-094846.md) | [(4.74)](/filings/0001104659-25-112443.md) | not reported | [(0.52)](/filings/0001104659-26-058614.md) | [(0.44)](/filings/0001104659-26-094846.md) |
| Basic EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | [(0.81)](/filings/0001104659-26-058614.md) | [(0.40)](/filings/0001104659-26-094846.md) | [(4.74)](/filings/0001104659-25-112443.md) | not reported | [(0.52)](/filings/0001104659-26-058614.md) | [(0.44)](/filings/0001104659-26-094846.md) |

- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2023-09-30) | period not labelled (2023-12-31) | period not labelled (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [1.6](/filings/0001558370-25-003534.md) | not reported | [1.5](/filings/0001558370-24-011642.md) | [1.1](/filings/0001558370-24-015538.md) | [1.2](/filings/0001104659-26-034594.md) | [1.1](/filings/0001558370-25-007741.md) | [2.7](/filings/0001558370-25-011551.md) | [1.0](/filings/0001104659-25-112443.md) | [1.3](/filings/0001104659-26-094846.md) | [1.0](/filings/0001104659-26-058614.md) | [6.7](/filings/0001104659-26-094846.md) |
| Total assets | $m | not reported | [263](/filings/0001558370-25-003534.md) | not reported | [268](/filings/0001558370-24-011642.md) | [269](/filings/0001558370-24-015538.md) | [273](/filings/0001104659-26-034594.md) | [277](/filings/0001558370-25-007741.md) | [285](/filings/0001558370-25-011551.md) | [280](/filings/0001104659-25-112443.md) | [271](/filings/0001104659-26-094846.md) | [263](/filings/0001104659-26-058614.md) | [266](/filings/0001104659-26-094846.md) |
| Total liabilities | $m | not reported | [251](/filings/0001558370-25-003534.md) | not reported | [257](/filings/0001558370-24-011642.md) | [253](/filings/0001558370-24-015538.md) | [258](/filings/0001104659-26-034594.md) | [262](/filings/0001558370-25-007741.md) | [269](/filings/0001558370-25-011551.md) | [267](/filings/0001104659-25-112443.md) | [258](/filings/0001104659-26-094846.md) | [250](/filings/0001104659-26-058614.md) | [251](/filings/0001104659-26-094846.md) |
| Long-term debt | $m | not reported | [19.0](/filings/0001558370-25-003534.md) | not reported | [31.1](/filings/0001558370-24-011642.md) | [25.3](/filings/0001558370-24-015538.md) | [24.2](/filings/0001104659-26-034594.md) | [27.8](/filings/0001558370-25-007741.md) | [44.3](/filings/0001558370-25-011551.md) | [44.8](/filings/0001104659-25-112443.md) | [38.4](/filings/0001104659-26-094846.md) | [29.3](/filings/0001104659-26-058614.md) | [23.4](/filings/0001104659-26-094846.md) |
| Shareholders' equity | $m | [10.8](/filings/0001558370-24-015538.md) | [11.5](/filings/0001104659-26-034594.md) | [11.2](/filings/0001558370-25-011551.md) | [10.9](/filings/0001104659-25-112443.md) | [16.4](/filings/0001104659-25-112443.md) | [15.6](/filings/0001104659-26-094846.md) | [15.6](/filings/0001104659-26-094846.md) | [15.8](/filings/0001104659-26-094846.md) | [12.9](/filings/0001104659-25-112443.md) | [13.2](/filings/0001104659-26-094846.md) | [13.0](/filings/0001104659-26-094846.md) | [15.2](/filings/0001104659-26-094846.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2023-09-30) | period not labelled (2023-12-31) | period not labelled (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(233) d](/filings/0001558370-24-015538.md) | [(629) d](/filings/0001558370-25-003534.md) | [(1,008)](/filings/0001558370-25-007741.md) | [(830) d](/filings/0001558370-25-011551.md) | [483 d](/filings/0001104659-25-112443.md) | [(868) d](/filings/0001104659-26-034594.md) | [(853)](/filings/0001104659-26-058614.md) | [(445) d](/filings/0001104659-26-094846.md) | [(510) d](/filings/0001104659-25-112443.md) | [137 d](/filings/0001104659-26-034594.md) | [(487)](/filings/0001104659-26-058614.md) | [(226) d](/filings/0001104659-26-094846.md) |
| Capital expenditure | $k | [(150) d](/filings/0001558370-24-015538.md) | [0.9 d](/filings/0001558370-25-003534.md) | [27.7](/filings/0001558370-25-007741.md) | [20.6 d](/filings/0001558370-25-011551.md) | [57.2 d](/filings/0001104659-25-112443.md) | [0.4 d](/filings/0001104659-26-034594.md) | [46.2](/filings/0001104659-26-058614.md) | [5.9 d](/filings/0001104659-26-094846.md) | [7.9 d](/filings/0001104659-25-112443.md) | [44.9 d](/filings/0001104659-26-034594.md) | [0.0](/filings/0001104659-26-058614.md) | [22.1 d](/filings/0001104659-26-094846.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [703](/filings/0001104659-26-058614.md) | [703](/filings/0001104659-26-094846.md) | [704](/filings/0001104659-25-112443.md) | [705](/filings/0001104659-26-058614.md) | [712](/filings/0001104659-26-094846.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 1,014,220 at 2026-08-12, from the cover of the [10-Q filed 2026-08-12](/filings/0001104659-26-094846.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.